Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.

Urologic oncology - 1 Jan 2000

Li He-Cheng, Albert Jeffrey M, Shinohara Eric T, Cai Qiuyin, Freyer Andrea, Cai Hui, Cao Carolyn, Wang Zuofei, Kataoka Nobuhiko, Teng Ming, Zheng Wei, Lu Bo

Abstract excerpt

BACKGROUND: -160C-->A and -347G-->GA polymorphisms in the promoter region decrease E-cadherin gene transcription. Decreased E-cadherin expression predicts poor outcome among patients with cancer. We sought to investigate whether -160C-->A and/or -347G-->GA polymorphisms were associated with the aggressiveness of prostate cancer. METHODS: TaqMan single nucleotide polymorphism genotyping assay (Applied Biosystems,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cadherins

Share to Neoplasm Invasiveness

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Share to Survival Analysis

Share to White People

Source

Identifiers

PMID: 17138130
DOI: 10.1016/j.urolonc.2006.02.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.PMID 17138130Read ↗

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.Semantic proximity Read ↗

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.Semantic proximity Read ↗

The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 promoter polymorphism is not associated with the aggressiveness of disease in prostate cancer.Semantic proximity Read ↗

Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.Semantic proximity Read ↗

E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.Semantic proximity Read ↗

Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.Semantic proximity Read ↗

The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.Semantic proximity Read ↗

-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.Semantic proximity Read ↗

Genetic variant associated with aggressive not indolent prostate cancer.Semantic proximity Read ↗

E-cadherin gene polymorphism and risk of urothelial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.